Patents
More topics under "C07B - General methods of organic chemistry; Apparatus therefor" (102,321)
C07B 31 - Reduction in general (2,354)
C07B 33 - Oxidation in general (640)
C07B 35 - Reactions without formation or introduction of functional groups containing hetero atoms, involving a change in the type of bonding between two carbon atoms already directly linked (1,427)
C07B 37 - Reactions without formation or introduction of functional groups containing hetero atoms, involving either the formation of a carbon-to-carbon bond between two carbon atoms not directly linked already or the disconnection of two directly linked carbon atoms (2,877)
C07B 39 - Halogenation (1,839)
C07B 41 - Formation or introduction of functional groups containing oxygen (3,087)
C07B 43 - Formation or introduction of functional groups containing nitrogen (1,809)
C07B 45 - Formation or introduction of functional groups containing sulfur (608)
C07B 47 - Formation or introduction of functional groups not provided for in groups (421)
C07B 49 - Grignard reactions (286)
C07B 51 - Introduction of protecting groups or activating groups, not provided for in groups (403)
C07B 53 - Asymmetric syntheses (6,231)
C07B 55 - Racemisation; Complete or partial inversion (688)
C07B 57 - Separation of optically-active organic compounds (3,737)
C07B 59 - Introduction of isotopes of elements into organic compounds (2,678)
C07B 60 - Generation of organic free radicals (107)
C07B 61 - Other general methods (69,072)
C07B 63 - Purification; Separation specially adapted for the purpose of recovering organic compounds; Stabilisation; Use of additives (4,057)
Patents for C07B - General methods of organic chemistry; Apparatus therefor (325)
05/2004
05/21/2004WO2004041752A2 Chemical encoding technology for combinatorial synthesis
04/2004
04/22/2004WO2004033390A2 Methods of preparing tocopherol compound salts in supercritical media
04/21/2004EP1409472A1 Method for the preparation of escitalopram
04/20/2004US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents
04/15/2004WO2004031105A2 Use of a33 antigens and jam-it
04/15/2004CA2498631A1 Use of a33 antigens and jam-it
04/14/2004CN1145473C Keratin fibers oxidation dyeing composition and dyeing method using same
04/07/2004EP1102733B1 Method for reacting an organic compound with a hydroperoxide
03/2004
03/31/2004EP1402024A2 Templated molecules and methods for using such molecules
03/25/2004US20040058168 For tinting a polymer
03/09/2004US6703528 Process for producing carbonyl or hydroxy compound
02/2004
02/25/2004CN1139595C Crystalline macrolides and its preparation method
01/2004
01/29/2004WO2004009517A2 Method for incorporating anionic molecules into a substrate for increasing dispersibility of anionic molecules
01/08/2004WO2003078625A3 An improved method for synthesising templated molecules
11/2003
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/04/2003US6641618 Ready-to-use aqueous composition for bleaching keratin fibers, comprising a combination of a water-soluble solvent and a nonionic and/or anionic amphiphilic polymer comprising at least one fatty chain
10/2003
10/22/2003EP1047665B1 Matrix metalloprotease inhibitors
09/2003
09/25/2003WO2003078625A2 An improved method for synthesising templated molecules
09/25/2003CA2518626A1 An improved method for synthesising templated molecules
09/11/2003US20030171568 Diagnosing tumor or cancer in a mammal, and inflammatory diseases or disorders; inflammatory bowel disease, colon cancer; immunoassay, immunotherapy
09/03/2003CN1119988C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/03/2003CN1119987C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
08/2003
08/21/2003US20030158206 Sildenafil mesylate for the treatment of male erectile dysfunction or female sexual disorders.
08/19/2003US6608033 Treatment or prevention of coccidiosis
06/2003
06/26/2003WO2003051861A1 Method for the preparation of escitalopram
06/26/2003CA2470225A1 Method for the preparation of escitalopram
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/19/2003US20030114706 Aminomethylphosphonic acid is contacted with water, an alcohol, a phenol and an oxidizing gas in the presence of a catalyst
06/03/2003CA2275554C Intranasal formulations for treating sexual disorders
03/2003
03/18/2003CA2223722C Keratin fibre oxidation dye composition and dye process using the composition
02/2003
02/11/2003CA2223726C Keratin fibre oxidation dye composition and dye process using the composition
02/11/2003CA2222851C Keratin fibre oxidation dye composition and dye process using the composition
01/2003
01/23/2003WO2003006449A1 Method for the preparation of escitalopram
12/2002
12/27/2002WO2002103008A2 Templated molecules and methods for using such molecules
12/27/2002CA2451524A1 Templated molecules and methods for using such molecules
11/2002
11/12/2002US6479680 Method for reacting an organic compound with a hydroperoxide
09/2002
09/11/2002EP0973729B1 A process for the preparation of 4-bromomethyl diphenyl compounds
08/2002
08/13/2002US6432146 Use of a combination of two cationic dyes for the direct dyeing of keratin fibers
08/06/2002US6428580 Oxidizing mixture containing ascorbic acid, metal compound and oxidizer
07/2002
07/23/2002US6423722 Antiinflammatory agents
07/16/2002US6419710 Mixture containing oxidoreductase enzyme
05/2002
05/22/2002CN1085208C Process for preparing eprosartan
05/08/2002CN1347861A Process for producing carbonyl & hydroxy compound
04/2002
04/30/2002US6379401 Alkaline agent, peroxygen salt and polymer thickeners and nonionic surfactant
04/04/2002US20020040139 Intranasal formulations for treating sexual disorders
03/2002
03/20/2002EP1188735A1 Process for producing carbonyl or hydroxy compound
02/2002
02/28/2002US20020025906 Process for producing carbonyl or hydroxy compound
02/26/2002US6350907 Matrix metalloprotease inhibitors
02/12/2002US6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
11/2001
11/14/2001CN1322186A Method for reacting organic compound with hydroperoxide
10/2001
10/18/2001US20010031889 Catalytically reacting an aminomethylphosphonic acid with a reagent selected from water, a phenol, and/or an alcohol, and an oxidizing gas under controlled reaction conditions to improve selectivity and yield
07/2001
07/19/2001US20010008031 Oxidizing mixture containing ascorbic acid, metal compound and oxidizer
05/2001
05/30/2001EP1102733A1 Method for reacting an organic compound with a hydroperoxide
05/01/2001US6225385 Oligomeric stabilizer mixture
04/2001
04/17/2001US6218570 Method for preparing formylphosphonic acid
03/2001
03/07/2001EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
03/07/2001CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system
02/2001
02/28/2001EP1078631A1 Use of macrolide antibiotics for the treatment or prevention of coccidiosis
02/28/2001CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
02/27/2001US6194609 Crystallization in a plate heat exchanger
02/27/2001CA2316647A1 Treatment or prevention of coccidiosis
02/21/2001CN1284942A Matrix metalloprotease inhibitors
01/2001
01/31/2001CN1281694A Composite for oxidation-dyeing keratin fibre and its dyeing method
01/09/2001US6172237 Process for preparing eprosartan
11/2000
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
10/2000
10/18/2000CN1270021A Anhydrous composition for bleaching keratin fibers
10/18/2000CN1270020A Aqueous composition for bleaching keratin fibers instantaneously
09/2000
09/20/2000EP1036558A1 Anhydrous composition for decoloration of ceratinic fibers comprising a combination of a hydrosoluble thickening polymer and an amphiphilic nonionic polymer carrying a fatty grain
09/20/2000CN1267212A Use of ascorbic acid in permanent waving and hair coloring compositions
09/06/2000CN1265307A Application of two kinds of cationic dye mixture in direct dyeing of keratin fiber
08/2000
08/30/2000EP1031343A1 Ready-to-use aqueous composition for bleaching of hair, containing a water soluble solvent and a non-ionic amphiphilic or anionic polymer with at least one fatty chain
08/29/2000US6111114 4-bromomethyldiphenyl substituted by 2'-cyano,-carboxy, carbonyloxy or carboxyamide prepared by brominating the corresponding 4-methyl compound using bromine or aqueous hydrobromine solution in the presence of hydrogen peroxide
08/23/2000EP1029529A1 Composition for oxidative dyeing of keratinous fibres and dyeing process using same
08/23/2000EP1028701A2 Use of ascorbic acid in permanent waving and hair coloring compositions
08/16/2000CA2298190A1 Compound for oxidation dying of keratinous fibres and dying process using the said compound
08/09/2000EP1025834A1 Use for direct hair dye a combination of two cationic dyes
07/2000
07/26/2000CN1261365A Crystalline macrolides and process for their preparation
07/05/2000EP1016405A2 Arylating medicaments
05/2000
05/31/2000CN1255137A Method for preparing formylphosphonic acid
05/17/2000CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction
04/2000
04/26/2000EP0994880A1 Crystalline macrolides and process for their preparation
04/25/2000US6054608 Reacting aminomethylphosphonate with water or alcohol or phenol derivative in presence of catalyst and oxidizing gas to form formylphosphonic acid
04/21/2000CA2286646A1 Process and intermediates for preparing nicotinamide derivatives
03/2000
03/22/2000EP0986566A1 Method for preparing formylphosphonic acid
03/15/2000CN1247539A Process for preparing eprosartan
02/2000
02/17/2000WO2000007965A1 Method for reacting an organic compound with a hydroperoxide
02/17/2000DE19835907A1 Verfahren zur Umsetzung einer organischen Verbindung mit einem Hydroperoxid A process for reacting an organic compound with a hydroperoxide
02/17/2000CA2339710A1 Process for the reaction of an organic compound with a hydroperoxide
02/09/2000EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
01/2000
01/26/2000EP0973729A1 A process for the preparation of 4-bromomethyl diphenyl compounds
01/12/2000EP0970073A1 Process for preparing eprosartan
12/1999
12/29/1999EP0967214A1 Intranasal formulations for treating sexual disorders
11/1999
11/30/1999US5993490 Composition for the oxidation dyeing of keratin fibers containing a cationic direct dye and dyeing process using this composition
09/1999
09/23/1999DE19812224A1 Oligomeres Stabilisatorgemisch Oligomeric stabilizer mixture
09/22/1999EP0943654A1 Mixture of oligomeric stabilizers
07/1999
07/15/1999WO1999035124A1 Matrix metalloprotease inhibitors
07/08/1999WO1999008650B1 Use of ascorbic acid in permanent waving and hair coloring compositions
07/06/1999US5919273 Ready-to-use composition dyes hair giving uniform color; oxidation base in combination with a substituted meta-aminophenol coupler, cationic direct dye and oxidizing agent; multicompartment dye kit
05/1999
05/14/1999WO1999008650A3 Use of ascorbic acid in permanent waving and hair coloring compositions
03/1999
03/09/1999US5879412 Compositions and processes for dyeing keratin fibers with an oxidation base, a coupler, a cationic direct dye, and an oxidizing agent
1 2 3 4